Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BTG1 Mutation Correlates with Inferior Prognosis in Diffuse Large B-Cell Lymphoma.

Cancer research and treatment - 1 Jul 2026

Shang Chun-Yu, Hua Wei, Xing Tong-Yao, Du Kai-Xin, Wu Yi-Fan, Li Yue, Yin Hua, Shen Hao-Rui, Wang Li, Li Jian-Yong, Gao Rui, Xu Wei, Liang Jin-Hua

Abstract excerpt

PURPOSE: B-cell translocation gene 1 (BTG1) is a highly conserved gene and recurrently mutated in the MCD subtype of diffuse large B-cell lymphoma (DLBCL). The specific enrichment of BTG1 mutation (BTG1mut) raises a potential hypothesis that they may actively contribute to DLBCL. However, the biological characteristics and prognostic signifi cance ofBTG1 in DLBCL remain to be explored. Therefore, the objective of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, Large B-Cell, Diffuse

Share to Mutation

Share to Neoplasm Proteins

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 40744809
DOI: 10.4143/crt.2025.494
PMCID: PMC13382550

Genes

BTG1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BTG1 Mutation Correlates with Inferior Prognosis in Diffuse Large B-Cell Lymphoma.PMID 40744809Read ↗

A novel molecular classification of diffuse large B cell lymphoma based on Metabolism-related genesSemantic proximity Read ↗

Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signatureSemantic proximity Read ↗

Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signatureSemantic proximity Read ↗

Identification of a 16-MTGs Prognostic Signature in Diffuse large B-cell lymphomaSemantic proximity Read ↗

Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphomaSemantic proximity Read ↗

Metabolic pathway-based subtyping reveals distinct microenvironmental states associated with diffuse large B-cell lymphoma outcomes.Semantic proximity Read ↗

[Analysis of the Gene Mutation Distribution and Its Relationship with Prognosis in Patients with Primary Gastrointestinal Diffuse Large B-Cell Lymphoma by Next Generation Sequencing].Semantic proximity Read ↗

Genetic landscape and prognostic value of IRF4 alterations in Diffuse large B-cell lymphoma patientsSemantic proximity Read ↗

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma.Semantic proximity Read ↗

Single cell transcriptomic analysis of diffuse large B cells in cerebrospinal fluid of central nervous system lymphomaSemantic proximity Read ↗

TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.